Association between degenerative aortic valve disease and long-term exposure to cardiovascular risk factors: results of the longitudinal population-based KORA/MONICA survey


Autoria(s): STRITZKE, Jan; LINSEL-NITSCHKE, Patrick; MARKUS, Marcello Ricardo Paulista; MAYER, Bjoern; LIEB, Wolfgang; LUCHNER, Andreas; DOERING, Angela; KOENIG, Wolfgang; KEIL, Ulrich; HENSE, Hans-Werner; SCHUNKERT, Heribert; MONICA KORA Investigators
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2009

Resumo

Degenerative aortic valve disease (DAVD), a common finding in the elderly, is associated with an increased risk of death due to cardiovascular causes. Taking advantage of its longitudinal design, this study evaluates the prevalence of DAVD and its temporal associations with long-term exposure to cardiovascular risk factors in the general population. We studied 953 subjects (aged 25-74 years) from a random sample of German residents. Risk factors had been determined at a baseline investigation in 1994/95. At a follow-up investigation, 10 years later, standardized echocardiography determined aortic valve morphology and aortic valve area (AVA) as well as left ventricular geometry and function. At the follow-up study, the overall prevalence of DAVD was 28%. In logistic regression models adjusting for traditional cardiovascular risk factors at baseline age (OR 2.0 [1.7-2.3] per 10 years, P < 0.001), active smoking (OR 1.7 [1.1-2.4], P = 0.009) and elevated total cholesterol levels (OR 1.2 [1.1-1.3] per increase of 20 mg/dL, P < 0.001) were significantly related to DAVD at follow-up. Furthermore, age, baseline status of smoking, and total cholesterol level were significant predictors of a smaller AVA at follow-up study. In contrast, hypertension and obesity had no detectable relationship with long-term changes of aortic valve structure. In the general population we observed a high prevalence of DAVD that is associated with long-term exposure to elevated cholesterol levels and active smoking. These findings strengthen the notion that smoking cessation and cholesterol lowering are promising treatment targets for prevention of DAVD.

Federal Ministry of Education and Research (BMBF)[FKZ 01GI0205]

Deutsche Forschungsgemeinschaft (DFG )[Schu 672/9-1]

Deutsche Forschungsgemeinschaft (DFG )[Schu 672/10-1]

Deutsche Forschungsgemeinschaft (DFG )[Schu 672/12-1]

Bundesministerium fur Forschung und Technologie (BMBF)

Medical Faculty, University of Lubeck[A39-2005]

EU[LSH-2005-037593]

GSF-National Research Centre for Environment and Health

German Federal Ministry of Education, Science, Research and Technology

State of Bavaria

Identificador

EUROPEAN HEART JOURNAL, v.30, n.16, p.2044-2053, 2009

0195-668X

http://producao.usp.br/handle/BDPI/23255

10.1093/eurheartj/ehp287

http://dx.doi.org/10.1093/eurheartj/ehp287

Idioma(s)

eng

Publicador

OXFORD UNIV PRESS

Relação

European Heart Journal

Direitos

restrictedAccess

Copyright OXFORD UNIV PRESS

Palavras-Chave #Epidemiology #Degenerative aortic valve disease #Risk factor #Cholesterol #Smoking #LEFT-VENTRICULAR MASS #CLINICAL-SIGNIFICANCE #FIBROUS SKELETON #LOWERING THERAPY #POMERANIA SHIP #STENOSIS #PROGRESSION #CALCIFICATION #HEALTH #ECHOCARDIOGRAPHY #Cardiac & Cardiovascular Systems
Tipo

article

original article

publishedVersion